Related Experiment Video
Updated: Jul 12, 2025

Fetal Echocardiography and Pulsed-wave Doppler Ultrasound in a Rabbit Model of Intrauterine Growth Restriction
Published on: June 29, 2013
Exploring the Genetic Causes for Postnatal Growth Failure in Children Born Non-Small for Gestational Age
Yoo-Mi Kim1,2, Han-Hyuk Lim2,3, Eunhee Kim1,2
1Department of Pediatrics, Chungnam National University Sejong Hospital, Sejong 30099, Republic of Korea.
Insights
Genetic testing identified the causes of short stature (SS) in over 40% of children with familial short stature (FSS) and idiopathic short stature (ISS). This genetic insight may guide growth hormone (GH) therapy effectiveness for non-small for gestational age (non-SGA) children.
Area of Science:
- Pediatric Endocrinology
- Human Genetics
- Molecular Biology
Background:
- Familial short stature (FSS) and idiopathic short stature (ISS) are common in children.
- Growth plate dysfunction is increasingly recognized as a genetic basis for FSS and ISS.
- Understanding the genetic underpinnings is crucial for effective treatment strategies.
Purpose of the Study:
- To investigate monogenic causes of growth failure in patients with ISS and FSS.
- To analyze the response to growth hormone (GH) therapy in genetically characterized patients.
- To determine the diagnostic yield of targeted exome sequencing for these conditions.
Main Methods:
- Targeted exome sequencing was performed on patients diagnosed with ISS or FSS.
- Genetic variants and copy number variations were identified.
- Response to GH therapy was assessed in genetically confirmed cases.
Main Results:
- A genetic cause was identified in 45.5% of FSS and 35.7% of ISS patients.
- The diagnostic yield was 41.7% overall, with higher rates in syndromic (90%) versus non-syndromic (23.1%) short stature.
- Genetically confirmed patients showed significant height improvement with GH therapy (from -2.6 to -1.3 SDS).
- Identified genetic causes involved pathways like paracrine signaling, extracellular matrix, and intracellular processes.
Conclusions:
- Monogenic growth failure is a significant contributor to FSS and ISS.
- Targeted exome sequencing is effective in diagnosing genetic causes of short stature.
- Identifying the specific genetic etiology can inform prognosis and guide GH therapy decisions for non-small for gestational age (non-SGA) children.
Abstract:
The most common causes of short stature (SS) in children are familial short stature (FSS) and idiopathic short stature (ISS). Recently, growth plate dysfunction has been recognized as the genetic cause of FSS or ISS. The aim of this study was to investigate monogenic growth failure in patients with ISS and FSS. Targeted exome sequencing was performed in patients categorized as ISS or FSS and the subsequent response to growth hormone (GH) therapy was analyzed. We found 17 genetic causes involving 12 genes (NPR2, IHH, BBS1, COL1A1, COL2A1, TRPS1, MASP1, SPRED1, PTPTN11, ADNP, NADSYN1, and CERT1) and 2 copy number variants. A genetic cause was found in 45.5% and 35.7% of patients with FSS and ISS, respectively. The genetic yield in patients with syndromic and non-syndromic SS was 90% and 23.1%, respectively. In the 11 genetically confirmed patients, a gain in height from -2.6 to -1.3 standard deviations after 2 years of GH treatment was found. The overall diagnostic yield in this study was 41.7%. We identified several genetic causes involving paracrine signaling, the extracellular matrix, and basic intracellular processes. Identification of the causative gene may provide prognostic evidence for the use of GH therapy in non-SGA children.
Related Concept Videos
Nature and Nurture
Inborn Errors of Metabolism
Teratogenicity
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...

